Counseling and Recovery Center Inc is a licensed substance use treatment provider in Fort Pierce, FL, listed in the SAMHSA treatment directory. Outpatient care is offered, so clients can keep living at home between scheduled sessions. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientOutpatient day treatment or partial hospitalizationOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatment
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicaidSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyCommission on Accreditation of Rehabilitation Facilities (CARF)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
1302 North Lawnwood Circle, Suite B, Fort Pierce, FL 34950
OutpatientOutpatient detoxificationOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare
Hospital inpatient/24-hour hospital inpatientHospital inpatient detoxificationHospital inpatient treatmentFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
OutpatientOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentFederal military insurance (e.g., TRICARE)Private health insurance
1680 SE Lyngate Drive, Suite 204, Port Saint Lucie, FL 34952
OutpatientOutpatient detoxificationOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare